X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (188000) 188000
Book Chapter (475) 475
Magazine Article (418) 418
Book / eBook (251) 251
Newspaper Article (113) 113
Conference Proceeding (63) 63
Newsletter (59) 59
Paper (33) 33
Dissertation (30) 30
Publication (30) 30
Government Document (28) 28
Reference (13) 13
Web Resource (12) 12
Report (10) 10
Trade Publication Article (10) 10
Book Review (7) 7
Streaming Video (4) 4
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (173471) 173471
index medicus (133783) 133783
female (104889) 104889
male (99448) 99448
middle aged (75063) 75063
aged (62192) 62192
adult (61702) 61702
treatment outcome (45307) 45307
risk factors (38243) 38243
surgery (25159) 25159
retrospective studies (24282) 24282
care and treatment (24240) 24240
aged, 80 and over (23669) 23669
pharmacology & pharmacy (22658) 22658
oncology (22302) 22302
medicine & public health (21964) 21964
adolescent (21658) 21658
analysis (20657) 20657
health aspects (20149) 20149
research (19652) 19652
time factors (19230) 19230
management (18759) 18759
mortality (17957) 17957
young adult (17816) 17816
cancer (17292) 17292
animals (16339) 16339
drug therapy (16001) 16001
risk (15988) 15988
prospective studies (15756) 15756
patients (15648) 15648
therapy (15261) 15261
child (15221) 15221
medicine, general & internal (14969) 14969
abridged index medicus (14438) 14438
safety (14053) 14053
clinical trials (13774) 13774
cardiac & cardiovascular systems (13578) 13578
risk assessment (13087) 13087
follow-up studies (12402) 12402
studies (11762) 11762
chemotherapy (11514) 11514
complications and side effects (11324) 11324
prevention (10778) 10778
medicine (10766) 10766
double-blind method (10487) 10487
internal medicine (10481) 10481
double-blind (10361) 10361
efficacy (10294) 10294
children (10170) 10170
medical research (10059) 10059
incidence (9803) 9803
complications (9512) 9512
child, preschool (9425) 9425
usage (9398) 9398
hematology (9363) 9363
pediatrics (8774) 8774
dose-response relationship, drug (8650) 8650
adverse events (8364) 8364
antineoplastic agents - adverse effects (8162) 8162
public, environmental & occupational health (8135) 8135
immunology (8101) 8101
disease (8052) 8052
dosage and administration (8047) 8047
drugs (7860) 7860
diagnosis (7834) 7834
infant (7789) 7789
research article (7714) 7714
cohort studies (7614) 7614
clinical neurology (7582) 7582
trial (7460) 7460
outcomes (7444) 7444
drug therapy, combination (7430) 7430
gastroenterology & hepatology (7281) 7281
drug administration schedule (7259) 7259
toxicology (7179) 7179
randomized controlled trials as topic (7083) 7083
transplantation (7072) 7072
prevalence (7020) 7020
medicine, experimental (6979) 6979
peripheral vascular disease (6966) 6966
prognosis (6957) 6957
pharmacology/toxicology (6920) 6920
pregnancy (6824) 6824
toxicity (6773) 6773
risk-factors (6716) 6716
patient outcomes (6689) 6689
hospitals (6632) 6632
medicine, research & experimental (6627) 6627
quality of life (6528) 6528
severity of illness index (6472) 6472
united states (6395) 6395
antineoplastic combined chemotherapy protocols - adverse effects (6373) 6373
survival (6265) 6265
epidemiology (6252) 6252
antineoplastic combined chemotherapy protocols - therapeutic use (6070) 6070
pharmacology (5902) 5902
pain (5681) 5681
urology & nephrology (5608) 5608
age factors (5500) 5500
cardiology (5500) 5500
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (64) 64
Collection Dvlpm't (Acquisitions) - Vendor file (21) 21
Online Resources - Online (19) 19
UofT at Mississauga - Stacks (9) 9
Collection Dvlpm't (Acquisitions) - Closed Orders (8) 8
Robarts - Stacks (8) 8
UofT at Scarborough - Stacks (7) 7
Engineering & Comp. Sci. - Stacks (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (4) 4
New College (Ivey) - Stacks (2) 2
Robarts - Course Reserves (2) 2
Bridgepoint Health - Stacks (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Indust. Rel's & Hum. Resources (Newman) - Library use only (1) 1
OISE - Stacks (1) 1
Online (1) 1
Online Resources - Pharmacy (1) 1
Providence Healthcare - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (188200) 188200
French (528) 528
German (427) 427
Spanish (270) 270
Japanese (268) 268
Portuguese (82) 82
Italian (75) 75
Chinese (43) 43
Korean (29) 29
Russian (24) 24
Hungarian (18) 18
Polish (16) 16
Turkish (10) 10
Danish (8) 8
Dutch (8) 8
Czech (7) 7
Croatian (6) 6
Hebrew (5) 5
Norwegian (5) 5
Slovenian (5) 5
Lithuanian (4) 4
Bulgarian (2) 2
Romanian (2) 2
Arabic (1) 1
Finnish (1) 1
Icelandic (1) 1
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 2016, Volume 60, pp. 12 - 25
Journal Article
Journal Article
JNCI : Journal of the National Cancer Institute, ISSN 0027-8874, 2012, Volume 104, Issue 2, pp. 93 - 113
.... This has raised challenges in the management of adverse events (AEs) associated with the six targeted agents approved in RCC-sorafenib, sunitinib, pazopanib, bevacizumab... 
TYROSINE KINASE INHIBITORS | CONTROLLED-TRIAL | INTERFERON-ALPHA | SUNITINIB TREATMENT | CANCER-PATIENTS | VENOUS THROMBOEMBOLISM | ONCOLOGY | HEART-FAILURE | DOUBLE-BLIND | EXPANDED ACCESS PROGRAM | ENDOTHELIAL GROWTH-FACTOR | Niacinamide - analogs & derivatives | Hypothyroidism - chemically induced | Pneumonia - therapy | Anorexia - therapy | Humans | Drug Eruptions - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Kidney Neoplasms - metabolism | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Weight Loss - drug effects | Benzenesulfonates - adverse effects | Bevacizumab | TOR Serine-Threonine Kinases - antagonists & inhibitors | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Pyrroles - adverse effects | Antineoplastic Agents - pharmacology | Carcinoma, Renal Cell - drug therapy | Everolimus | Hypothyroidism - therapy | Wound Healing - drug effects | Molecular Targeted Therapy - methods | Sirolimus - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Sirolimus - analogs & derivatives | Europe | Gastrointestinal Tract - drug effects | Cardiovascular System - drug effects | Evidence-Based Medicine | Carcinoma, Renal Cell - metabolism | Indoles - adverse effects | Pyrimidines - adverse effects | Sulfonamides - adverse effects | Anorexia - chemically induced | Kidney Neoplasms - drug therapy | Protein-Tyrosine Kinases - antagonists & inhibitors | Antimitotic agents | Drugs | Complications and side effects | Care and treatment | Adverse and side effects | Carcinoma, Renal cell | Research | Drug therapy | Antineoplastic agents
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2012, Volume 30, Issue 21, pp. 2691 - 2697
.... We review the literature on managing the adverse effects and kinetics of tumor regression with ipilimumab and provide guidelines on their management... 
REGRESSION | METASTATIC MELANOMA | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | EFFICACY | ONCOLOGY | PHASE-II | MONOCLONAL-ANTIBODY | CTLA-4 | PATIENT | CANCER-IMMUNOTHERAPY | BLOCKADE | Stevens-Johnson Syndrome - immunology | Peripheral Nervous System Diseases - chemically induced | Skin Neoplasms - drug therapy | Humans | Ipilimumab | Antibodies, Monoclonal - adverse effects | Scleritis - chemically induced | Antineoplastic Agents - administration & dosage | Liver - immunology | Liver - drug effects | Antineoplastic Agents - adverse effects | Diarrhea - immunology | Pancreatitis - immunology | Scleritis - immunology | Mucous Membrane - drug effects | Colitis - immunology | Peripheral Nervous System Diseases - immunology | Antibodies, Monoclonal - immunology | Drug Eruptions - immunology | Skin - immunology | Melanoma - metabolism | Skin Neoplasms - pathology | Skin Neoplasms - immunology | Antineoplastic Agents - immunology | CTLA-4 Antigen - drug effects | Lymphatic Diseases - immunology | Antibodies, Monoclonal - pharmacokinetics | CTLA-4 Antigen - immunology | Pancreatitis - chemically induced | Melanoma - secondary | Chemical and Drug Induced Liver Injury - immunology | Pituitary Gland - immunology | Skin Neoplasms - metabolism | Lymphatic Diseases - chemically induced | Mucous Membrane - immunology | Antibodies, Monoclonal - administration & dosage | Melanoma - immunology | Uveitis - immunology | Melanoma - drug therapy | Uveitis - chemically induced | Pituitary Gland - drug effects | Skin - drug effects | Index Medicus
Journal Article
Journal Article
11.